272 related articles for article (PubMed ID: 15166968)
1. TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial.
Rosemurgy AS; Zervos EE; Clark WC; Thometz DP; Black TJ; Zwiebel BR; Kudryk BT; Grundy LS; Carey LC
Ann Surg; 2004 Jun; 239(6):883-9; discussion 889-91. PubMed ID: 15166968
[TBL] [Abstract][Full Text] [Related]
2. Management of refractory chylous ascites with peritoneovenous shunts.
Huang Y; Gloviczki P; Duncan AA; Fleming MD; Driscoll DJ; Kalra M; Oderich GS; Bower TC
J Vasc Surg Venous Lymphat Disord; 2017 Jul; 5(4):538-546. PubMed ID: 28623993
[TBL] [Abstract][Full Text] [Related]
3. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
4. LeVeen vs Denver peritoneovenous shunts for intractable ascites of cirrhosis. A randomized, prospective trial.
Fulenwider JT; Galambos JD; Smith RB; Henderson JM; Warren WD
Arch Surg; 1986 Mar; 121(3):351-5. PubMed ID: 3947233
[TBL] [Abstract][Full Text] [Related]
5. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality.
Russo MW; Sood A; Jacobson IM; Brown RS
Am J Gastroenterol; 2003 Nov; 98(11):2521-7. PubMed ID: 14638358
[TBL] [Abstract][Full Text] [Related]
6. Denver peritoneovenous shunts for the management of malignant ascites: a review of the literature in the post LeVeen Era.
White MA; Agle SC; Padia RK; Zervos EE
Am Surg; 2011 Aug; 77(8):1070-5. PubMed ID: 21944526
[TBL] [Abstract][Full Text] [Related]
7. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
Henderson JM; Boyer TD; Kutner MH; Galloway JR; Rikkers LF; Jeffers LJ; Abu-Elmagd K; Connor J;
Gastroenterology; 2006 May; 130(6):1643-51. PubMed ID: 16697728
[TBL] [Abstract][Full Text] [Related]
8. Peritoneovenous shunts for malignant ascites.
Sonnenfeld T; Tydén G
Acta Chir Scand; 1986 Feb; 152():117-21. PubMed ID: 3953206
[TBL] [Abstract][Full Text] [Related]
9. Prosthetic H-graft portacaval shunts vs transjugular intrahepatic portasystemic stent shunts: 18-year follow-up of a randomized trial.
Rosemurgy AS; Frohman HA; Teta AF; Luberice K; Ross SB
J Am Coll Surg; 2012 Apr; 214(4):445-53; discussion 453-5. PubMed ID: 22463885
[TBL] [Abstract][Full Text] [Related]
10. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
[TBL] [Abstract][Full Text] [Related]
11. [Long-term follow up after surgery for intractable ascites].
Bancu L; Bara T; Jimboreanu O; Mureşan M; Bancu S
Chirurgia (Bucur); 2009; 104(6):719-21. PubMed ID: 20187471
[TBL] [Abstract][Full Text] [Related]
12. Peritoneovenous shunting in intractable ascites.
Deans GT; Spence RA; Johnston GW
Ulster Med J; 1985 Oct; 54(2):155-9. PubMed ID: 4095803
[TBL] [Abstract][Full Text] [Related]
13. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
Saad WE; Darwish WM; Davies MG; Waldman DL
J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
[TBL] [Abstract][Full Text] [Related]
14. Peritoneovenous shunts in patients with intractable ascites: palliation at what price?
Zervos EE; McCormick J; Goode SE; Rosemurgy AS
Am Surg; 1997 Feb; 63(2):157-62. PubMed ID: 9012430
[TBL] [Abstract][Full Text] [Related]
15. Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis.
Deltenre P; Mathurin P; Dharancy S; Moreau R; Bulois P; Henrion J; Pruvot FR; Ernst O; Paris JC; Lebrec D
Liver Int; 2005 Apr; 25(2):349-56. PubMed ID: 15780061
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous implant of Denver peritoneo-venous shunt for treatment of refractory ascites: a single center retrospective study.
Piccirillo M; Rinaldi L; Leongito M; Amore A; Crispo A; Granata V; Aprea P; Izzo F
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3668-3673. PubMed ID: 28925475
[TBL] [Abstract][Full Text] [Related]
17. Palliative treatment of malignant refractory ascites by positioning of Denver peritoneovenous shunt.
Zanon C; Grosso M; Aprà F; Clara R; Bortolini M; Quaglino F; Cornaglia S; Simone P
Tumori; 2002; 88(2):123-7. PubMed ID: 12088251
[TBL] [Abstract][Full Text] [Related]
18. Peritoneovenous shunting for intractable ascites.
Tyden G; Samnegård H; Thulin L
Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
[TBL] [Abstract][Full Text] [Related]
19. Use of Peritoneovenous Shunt for the Management of Refractory Ascites.
Ayllón MD; Ciria R; Gómez-Luque I; Rodriguez-Perálvarez M; Padial A; Luque A; López-Cillero P; de la Mata M; Briceño J
Transplant Proc; 2019; 51(1):41-43. PubMed ID: 30655143
[TBL] [Abstract][Full Text] [Related]
20. Peritoneovenous shunting is an effective treatment for intractable ascites.
Sooriakumaran P; McAndrew HF; Kiely EM; Spitz L; Pierro A
Postgrad Med J; 2005 Apr; 81(954):259-61. PubMed ID: 15811892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
